» Articles » PMID: 15564457

Lytic Cycle Gene Regulation of Epstein-Barr Virus

Overview
Journal J Virol
Date 2004 Nov 27
PMID 15564457
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Episomal reporter plasmids containing the Epstein-Barr virus (EBV) oriP sequence stably transfected into Akata Burkitt's lymphoma cells were used to analyze EBV lytic cycle gene regulation. First, we found that the Zp promoter of EBV, but not the Rp promoter, can be activated in the absence of protein synthesis in these oriP plasmids, casting doubt on the immediate early status of Rp. An additional level of regulation of Zp was implied by analysis of a mutation of the ZV element. Second, our analysis of late lytic cycle promoters revealed that the correct relative timing, dependence on ori lyt in cis, and sensitivity to inhibitors of DNA replication were reconstituted on the oriP plasmids. Late promoter luciferase activity from oriP plasmids also incorporating replication-competent ori lyt was phosphonoacetic acid sensitive, a hallmark of EBV late genes. A minimal ori lyt, which only replicates weakly, was sufficient to confer late timing of expression specifically on late promoters. Finally, deletion analysis of EBV late promoter sequences upstream of the transcription start site confirmed that sequences between -49 and +30 are sufficient for late gene expression, which is dependent on ori lyt in cis. However, the TATT version of the TATA box found in many late genes was not essential for late expression.

Citing Articles

Dendrosomal nanocurcumin prevents EBV-associated cell transformation by targeting the lytic cycle genes of the Epstein-Barr virus in the generation of lymphoblastoid cell line.

Cheragh M, Sadeghizadeh M, Pouriayevali M, Parsania M Iran J Basic Med Sci. 2023; 26(10):1220-1226.

PMID: 37736518 PMC: 10510484. DOI: 10.22038/IJBMS.2023.69839.15199.


Better late than never: A unique strategy for late gene transcription in the beta- and gammaherpesviruses.

Dremel S, Didychuk A Semin Cell Dev Biol. 2022; 146:57-69.

PMID: 36535877 PMC: 10101908. DOI: 10.1016/j.semcdb.2022.12.001.


PCR Detection of Epstein-Barr Virus (EBV) DNA in Patients with Head and Neck Squamous Cell Carcinoma, in Patients with Chronic Tonsillitis, and in Healthy Individuals.

Strzelczyk J, Swietek A, Biernacki K, Golabek K, Gazdzicka J, Miskiewicz-Orczyk K Biomed Res Int. 2022; 2022:8506242.

PMID: 35993047 PMC: 9381848. DOI: 10.1155/2022/8506242.


Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.

Zheng X, Huang Y, Li K, Luo R, Cai M, Yun J Viruses. 2022; 14(5).

PMID: 35632758 PMC: 9146158. DOI: 10.3390/v14051017.


Replication Compartments-The Great Survival Strategy for Epstein-Barr Virus Lytic Replication.

Sugimoto A Microorganisms. 2022; 10(5).

PMID: 35630341 PMC: 9144946. DOI: 10.3390/microorganisms10050896.


References
1.
Hall K, Stevenson A, Goodwin D, Gibson P, Markham A, Whitehouse A . The activation domain of herpesvirus saimiri R protein interacts with the TATA-binding protein. J Virol. 1999; 73(12):9756-63. PMC: 113022. DOI: 10.1128/JVI.73.12.9756-9763.1999. View

2.
Serio T, Cahill N, Prout M, Miller G . A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle. J Virol. 1998; 72(10):8338-43. PMC: 110205. DOI: 10.1128/JVI.72.10.8338-8343.1998. View

3.
Farrell P, Bankier A, Seguin C, Deininger P, Barrell B . Latent and lytic cycle promoters of Epstein-Barr virus. EMBO J. 1983; 2(8):1331-8. PMC: 555279. DOI: 10.1002/j.1460-2075.1983.tb01588.x. View

4.
Bell P, Lieberman P, Maul G . Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol. 2000; 74(24):11800-10. PMC: 112463. DOI: 10.1128/jvi.74.24.11800-11810.2000. View

5.
Kraus R, Mirocha S, Stephany H, Puchalski J, Mertz J . Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus. J Virol. 2001; 75(2):867-77. PMC: 113983. DOI: 10.1128/JVI.75.2.867-877.2001. View